08 March 2018

King & Wood Mallesons advises Yunfeng Fund and MicroPort jointly acquired LivaNova PLC’s cardiac rhythm management business ranking fifth largest in the world

On February 20, 2018, Yunfeng Fund signed the agreement with MicroPort Scientific Corporation ("MicroPort", HK:853), a medical company listed in Hong Kong, jointly acquiring cardiac rhythm management business (CRM business) of LivaNova PLC in the United Kingdom by funding MicroPort Cardiac Rhythm B.V. ("MicroPort Cardiac").

The business mainly includes R&D, manufacture and sale of pacemakers, defibrillators and cardiac resynchronization devices with the purchase price of 190 million U.S. dollars. Upon completion of the acquisition, Yunfeng Fund will indirectly hold 25% of the CRM business through MicroPort Cardiac.

LivaNova was merged by Sorin Biomedical and Cyberonics, the two largest Italian medical device companies in 2015. Its CRM business unit focuses on R&D, manufacture and sale of high-end medical device for identification, treatment and management of arrhythmia and heart failure with 40 years’ industry experience ranking fifth in the world. Through years of growth and innovation, MicroPort has become a premier medical solution provider covering 10 major medical disciplines including interventional cardiology, orthopedics, interventional radiology, electrophysiology, diabetes and endocrine management, surgical management, and others. With the completion of this acquisition, MicroPort will become one of the world's leading suppliers of CRM equipment bringing a strong competition in global market. In addition, with excellent resources from Yunfeng Fund, MicroPort will achieve leaping development in the field of domestic CRM equipment and share the fast-growing dividends in China's CRM market.

King & Wood Mallesons represented Yunfeng Fund and provided full support including communicating and negotiating with MicroPort and their legal team, preparing the transaction documents, and facilitating the signing and delivery. KWM team completed rounds of negotiations with MicroPort team within a relatively short time because of our rich project experience and efficient work and contributed to close the deal smoothly between Yunfeng Fund and MicroPort.

The Project above was led by Partner Zhang Yi and Zheng Hui, and supported by Lawyer Dong Yuting, Zhang Cheng, Wang Ye and Lou Xiaohan.

Media contact

Share on LinkedIn Share on Facebook Share on Twitter Share on Google+
    You might also be interested in

    Shanda Games Limited ("Shanda Games") has officially introduced in strategic investor Tencent.

    02 March 2018

    King & Wood Mallesons (KWM) advised a consortium of banks lead by Bank of China, ICBC, China Construction Bank and Export-Import Bank of China, in the EUR 3.7 billion Refinancing of Midea Gruppe...

    28 February 2018

    Mr. Gao Feng has been named to 2018 China TOP 15 Litigators by Asian Legal Business (ALB) for his excellent performance and wide recognition by clients.

    23 February 2018

    King & Wood Mallesons (KWM) was consecutively recognized as a Tier 1 firm in both trademark prosecution and trademark contentious in China for its outstanding performance.

    09 February 2018

    This publication has been downloaded from the King & Wood Mallesons website. It is provided only for your information and does not constitute legal or other advice on any specific matter. If you require or seek legal advice you should obtain such advice from your own lawyer, and should do so before taking, or refraining from taking, any action in reliance on this publication. If you have any questions, please contact King & Wood Mallesons. See www.kwm.com for more information.